IVD

Grail Stays at Forefront of Liquid Biopsy Conversation with New Results

The Menlo Park, CA-based company announced data validating the performance of its investigational multi-cancer early detection blood test for the first time in an independent cohort of participants.

A Blood Test for Brain Cancer with a Dash of AI Added

Researchers for the University of Strathclyde have developed the test, which uses infrared light to produce a "bio-signature" of a blood sample and applies artificial intelligence to check for the signs of cancer.

Qiagen and Illumina in It for the Long Haul with 15-year Collaboration

The two firms want to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics. The news comes as Qiagen’s CEO Peer Schatz announced he is stepping down.

New Breath Test Detects Opioid Use

A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians at the University of California, Davis. A breath test could be useful in caring for chronic pain patients as well as for checking for illegal drug use.

Can Bowel Cancer Screening Reduce Patient Death?

While a new study from the University of Australia points to the benefits of the use of pre-diagnostic colonoscopies, some patients are still hesitant about the procedure. This has caused companies to develop less invasive bowel cancer screening methods.

Roche Packs New FDA-Approved Test in Its Arsenal

The Basel, Switzerland-based company’s cobas Babesia test is a qualitative in vitro nucleic acid screening test for the direct detection of Babesia DNA and RNA in whole blood specimens from individual human blood donors.

Abbott’s FreeStyle Libre Catches Sanofi’s Eye in New Collaboration

Paris-based Sanofi will work with Abbott Laboratories to integrate glucose sensing and insulin delivery technologies to help improve diabetes management in patients. Abbott’s Freestyle Libre – a device that brought in $430 million in revenue for 2Q19, will be at the heart of the collaboration.

OncoCell MDx Rides the Liquid Biopsy Wave with New Financing

The Royal Oak, MI-based company has raised $22.2 million in a series B round and is developing a test for the detection of prostate cancer. Executives from OncoCell said the test could be available late next year.

OncoCyte Spells Out the Acquisition Plan for Razor Genomics

The Alameda, CA-based company said the deal could help it boost its lung cancer detection offerings.

A Young Biotech Company Garners Australian Design Award for Innovative Diagnostics

A portable device and inexpensive cartridges are designed to deliver quick and accurate diagnoses of infectious diseases without the need for a clinical laboratory.

Could Open-Access Diagnostics Speed Diagnoses?

LexaGene's automated screening technology for 22 known pathogens may also be able to help identify an unknown one.

Separating Plasma from Smaller and Smaller Blood Samples

Sample sizes of whole blood are reportedly shrinking. Can a biochemically enhanced material help diagnostic device designers separate enough plasma to support new testing efforts?

Study Finds Abbott’s Blood Test More Successful in Detecting TBI than CT Scans

The Abbott Park, IL-based company's test, which is still in development, was evaluated in the TRACK-TBI study.

Understanding Sodium Azide

A few tips on handling the diagnostic reagent preservative safely.

Abbott Targets Drug and Alcohol-Impaired Drivers in New Collaboration

Intoximeters will market its alcohol testing products along with Abbott’s SoToxa Mobile Test System – a handheld oral fluid roadside testing solution that detects recent drug use.

Supplier Stories for the Week of August 11

Here’s what was new in the world of medical device suppliers during the week of August 11.

Qmed Search Form